Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and Secondary Glioblastomas

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 3, 1998, Pages 239-245

  Tohma, Yasuo ^a   Gratas, Catherine ^a   Van Meir, Erwin G ^c   Desbaillets, Isabelle ^c   Tenan, Mirna ^c   Tachibana, Osamu ^a   Kleihues, Paul ^b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Fas; Hypoxia; Immunohistochemistry; Necrosis; P53 mutation; Primary glioblastoma; Secondary glioblastoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; MESSENGER RNA; PROTEIN P53; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ANOXIA; ANTIGEN EXPRESSION; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR NECROSIS; TUMOR SUPPRESSOR GENE;

EID: 0031916087     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199803000-00005     Document Type: Article

References (38)

1. Burger PC, Scheithauer BW. Tumors of the central nervous system. Washington: Armed Forces Institute of Pathology, 1994
2. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin Heidelberg: Springer Verlag, 1993
3. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68
4. Scherer HJ. Cerebral astrocytomas and their derivatives. Am J Cancer 1940;40:159-98
5. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-24
6. Daumas Duport C, Scheithauer B, O’Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62: 2152-65
7. Tachibana O, Lampe K, Kleihues P, Ohgaki H. Preferential expression of Fas/APOl (CtD95) and apoptotic cell death in perinecrotic cells of the glioblastoma multiforme. Acta Neuropathol 1996;92: 431-34
8. Koji T, Kobayashi N, Nakanishi Y, Yoshii A. Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cyto-chem 1994;27:459-63
9. Van Meir E, Ceska M, Effenberger F, et al. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 1992;52:4297-4305
10. Van Meir EG, Kikuchi T, Tada M, et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 1994; 54:649-52
11. Mercer WE, Shields MT, Amin M, et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990;87:6166-70
12. Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P, Ohgaki H. Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res 1995;55:5528-30
13. Weindel K, Marme D, Weich HA. AIDS-associated Kaposi’s sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 1992;183:1167-74
14. Lantos PL, VandenBerg SR. Kleihues. Tumours of the nervous system. Graham DI, Lantos PL, eds. Greenfield’s neuropathology. 6th ed. London: Arnold; 1996;9:583-879
15. Zulch KJ. Brain tumors. Their biology and pathology. 3rd ed. Berlin Heidelberg: Springer Verlag, 1986
16. Biernat W, Kleihues P, Yonekawa Y, Ohgaki H. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 1996;56:180-85
17. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-36
18. von Deimling A, von Ammon K, Schoenfeld D, Wiestier OD, Sei-zinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26
19. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987; 59:1617-25
20. Barker FG, Davis RL, Chang SM, Prados MD. Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 1996;77:1161-66
21. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 1983;52:550-54
22. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Na-gata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-17
23. Debatin KM, Suss D, Krammer PH. Differential expression of APO-1 on human thymocytes: Implications for negative selection? Eur J Immunol 1994;24:753-58
24. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. Curr Opin Immunol 1994;6:279-89
25. Rouvier E, Luciani MF, Golstein P. Fas involvement in Ca (2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993;177: 195-200
26. Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-29
27. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-79
28. Gratas C, Tohma Y, Van Meir EG, et al. Fas ligand expression in. glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol 1997;7:863-69
29. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994;94:954-64
30. Shiraishi T, Nakagawa S, Toda K, Kihara S, Ju Y, Tabuchi K. Anti-Fas antibody induces apoptosis in culture glioma cells by activation of the sphingomyelin pathway. In: Nagai M, ed. Brain tumor research and therapy. Tokyo: Springer-Verlag, 1995
31. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ, Fontana A. Fas/ APO-1 gene transfer for human malignant glioma. Cancer Res 1995;55:2936-44
32. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angio-genesis. Nature 1992;359:843-45
33. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-48
34. Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15:339-47
35. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th ed. London: Edward Arnold, 1989
36. Hempel SL, Monick MM, Hunninghake GW. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am J Respir Cell Mol Biol 1996;14:170-76
37. Owen Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3032-40
38. Tamura T, Aoyama N, Saya H, et al. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 1995;11:1939-46